Our results showed that treatment with MEK inhibitor increased the mRNA expression of LGR4 in human BRAFV600E-mutant CRC HT29 cells (Fig 5f) and BC mice (Fig. 5g), uncovering a negative association between the level of ERK phosphorylation and mRNA expression of Lgr4. Here, MAP2K7 is linked to breast cancer.